This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Romero, F I Articles by Hughes, G R. Search for Related Content PubMed PubMed Citation Articles by Romero, F I Articles by Hughes, G R. Social Bookmarking                         What's this?

Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis

Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, London, UK

M A Khamashta

Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, London SE1 7EH, UK. Tel: (+44) 171 620 2567; Fax: (+44) 171 620 2658

G RV Hughes

Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, London, UK

Lipoprotein(a) (Lp(a)) is considered a vascular pathogen of outstanding importance. High plasma levels of this lipoprotein are associated with premature arterial disease; however, the mechanisms involved have not been clarified. The atherosclerotic process is increasingly regarded as a chronic inflammatory reaction in the arterial wall where oxidation-mediated endothelial injury involving modified forms of low-density lipoprotein (LDL) seems to be a key event. Autoimmune pathways are involved in the progression of atherosclerosis and humoral response to oxidatively modified LDL can be considered among these pathways.

A number of factors can be encountered in the pathogenesis of the accelerated arterial disease seen in patients with antiphospholipid (Hughes) syndrome (APS) and systemic lupus erythematosus (SLE). Among these, high levels of Lp(a) have been described in both and increasing evidence indicates that patients with antiphospholipid antibodies (aPL) are under oxidative stress. Recent studies suggest that the so-called ‘oxidation theory of atherosclerosis’ may also be applied to Lp(a). This fact makes this lipoprotein potentially suitable as a target of the immune system and antibodies reacting against oxidatively-modified Lp(a) by malondialdehyde have been recently described in APS and SLE. It is therefore likely that an immune response to the oxidized moiety of Lp(a) might be influential in the pathogenicity of this lipoprotein and, subsequently, of atherosclerosis.

Key Words: atherosclerosis • systemic lupus erythematosus • antiphospholipid antibodies • oxidized LDL • oxidized Lp(a) • malondialdehyde-modified Lp(a)

Lupus, Vol. 9, No. 3, 206-209 (2000)
DOI: 10.1191/096120300678828253


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. Pepe, G. Chimienti, G. M. Liuzzi, B. L. Lamanuzzi, M. Nardulli, F. Lolli, E. Angles-Cano, and S. Mata Lipoprotein(a) in the Cerebrospinal Fluid of Neurological Patients with Blood-Cerebrospinal Fluid Barrier Dysfunction Clin. Chem., November 1, 2006; 52(11): 2043 - 2048. [Abstract] [Full Text] [PDF]

				J. M. P. de Godoy, F. Batigalia, M. R. P. de Godoy, A. C. Brandao, and D. R. S. Souza Anticardiolipin Antibodies as a Risk Factor of Atherosclerosis in Intermittent Claudication Angiology, July 1, 2004; 55(4): 357 - 359. [Abstract] [PDF]

				F J Lopez-Longo, N Caro, M I Almoguera, J Olazaran, J C Alonso-Farto, A Ortega, I Monteagudo, C M. Gonzalez, and L Carreno Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage Lupus, November 1, 2003; 12(11): 813 - 819. [Abstract] [PDF]

				B. Salobir, M. Sabovic, P. Peternel, and M. Stegnar Fibrinolytic Parameters and Lipoprotein(a) in Young Women with Myocardial Infarction Angiology, March 1, 2002; 53(2): 157 - 163. [Abstract] [PDF]

				H. A. Schenkein, C. R. Berry, D. Purkall, J. A. Burmeister, C. N. Brooks, and J. G. Tew Phosphorylcholine-Dependent Cross-Reactivity between Dental Plaque Bacteria and Oxidized Low-Density Lipoproteins Infect. Immun., November 1, 2001; 69(11): 6612 - 6617. [Abstract] [Full Text] [PDF]